Loading...
Loading...
Among the 4 tracked institutional investors we monitor, XLO (XILIO THERAPEUTICS INC) is held with a combined value of $1.64M across 1,355,127 shares. The largest holder is VANGUARD GROUP INC with a position worth $803.64K. 3 funds opened new positions in the most recent quarter.
Total Institutional Value
$1.64M
Total Shares Held
1,355,127
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $803.64K | 0.00% | - |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $416.85K | 0.00% | New |
| 3 | FMR LLC | $307.45K | 0.00% | New |
| 4 | STATE STREET CORP | $111.95K | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of XLO with a position worth $803.64K, representing 0.00% of their portfolio. In total, 4 institutional investors hold XLO with a combined value of $1.64M.
In the most recent quarter, 3 funds opened a new position in XLO.
Institutional investors hold $1.64M worth of XLO stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $803.64K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For XLO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their XLO positions.
Last Close
$8.65
2026-07-24
YTD
-8.0%
31% of 52-week range